Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 20 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Enzastaurin Versus Lomustine in Glioblastoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				Pharmaceutical / Industry				9817 H6Q-MC-JCBF, NCT00295815


2.		Phase 1/2 Study in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over				Pharmaceutical / Industry				9815 H6Q-MC-S008, NCT00402116

Last Modified: 1/12/2009 First Published: 11/24/2002


3.		Phase II Study of LY317615 in Patients With Recurrent High-Grade Gliomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				NCI-03-C-0018 NCT00052663


4.		Oral Enzastaurin HCl in Patients With Relapsed Mantle Cell Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				Pharmaceutical / Industry				8360 H6Q-MC-JCAO, NCT00088205


5.		Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer.

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				Pharmaceutical / Industry				8670 H6Q-MC-JCAQ, NCT00105092


6.		Enzastaurin for Patients With Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				19 and over				Pharmaceutical / Industry				9098 H6Q-MC-JCAR, NCT00192114


7.		Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Patients With Advanced or Metastatic Pancreatic Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				Pharmaceutical / Industry				10463 H6Q-US-S002, NCT00267020


8.		First Line Chemotherapy Treatment of Advanced NSCLC

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				10651 H6Q-US-S004, NCT00308750


9.		An Open Label Study of Oral Enzastaurin in Patients With Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				10287 H6Q-MC-S001, NCT00309140


10.		Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				Pharmaceutical / Industry				10517 H6Q-MC-S015, NCT00386087

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute